Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

A multicentre phase-II feasibility study evaluating gemcitabine/vinorelbine / prednisolone combination chemotherapy in relapsed / refractory Hodgkin's lymphoma.

Naqi N, Ahmad S, Shah I, Khattak J.

J Coll Physicians Surg Pak. 2013 Jun;23(6):397-400. doi: 06.2013/JCPSP.397400.

PMID:
23763798
[PubMed - indexed for MEDLINE]
2.

Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma.

Santoro A, Magagnoli M, Spina M, Pinotti G, Siracusano L, Michieli M, Nozza A, Sarina B, Morenghi E, Castagna L, Tirelli U, Balzarotti M.

Haematologica. 2007 Jan;92(1):35-41.

PMID:
17229633
[PubMed - indexed for MEDLINE]
Free Article
3.

Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report.

Cole PD, Schwartz CL, Drachtman RA, de Alarcon PA, Chen L, Trippett TM.

J Clin Oncol. 2009 Mar 20;27(9):1456-61. doi: 10.1200/JCO.2008.20.3778. Epub 2009 Feb 17.

PMID:
19224841
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Promising long-term outcome of gemcitabine, vinorelbine, liposomal doxorubicin (GVD) in 14-day schedule as salvage regimen for patients with previously heavily treated Hodgkin's lymphoma and aggressive non-Hodgkin's lymphoma.

Bai B, Huang HQ, Cai QQ, Wang XX, Cai QC, Lin ZX, Gao Y, Xia Y, Bu Q, Guo Y.

Med Oncol. 2013 Mar;30(1):350. doi: 10.1007/s12032-012-0350-5. Epub 2013 Jan 18.

PMID:
23329307
[PubMed - indexed for MEDLINE]
5.

Gemcitabine and vinorelbine combination is effective in both as a salvage and mobilization regimen in relapsed or refractory Hodgkin lymphoma prior to ASCT.

Suyanı E, Sucak GT, Akı ŞZ, Yeğin ZA, Özkurt ZN, Yağcı M.

Ann Hematol. 2011 Jun;90(6):685-91. doi: 10.1007/s00277-010-1113-z. Epub 2010 Nov 12.

PMID:
21072518
[PubMed - indexed for MEDLINE]
6.

Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma, results of a phase II single center study.

Müller-Beissenhirtz H, Kasper C, Nückel H, Dührsen U.

Ann Hematol. 2005 Nov;84(12):796-801. Epub 2005 Nov 12.

PMID:
16041531
[PubMed - indexed for MEDLINE]
7.

High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study.

Josting A, Sieniawski M, Glossmann JP, Staak O, Nogova L, Peters N, Mapara M, Dörken B, Ko Y, Metzner B, Kisro J, Diehl V, Engert A.

Ann Oncol. 2005 Aug;16(8):1359-65. Epub 2005 Jun 6.

PMID:
15939712
[PubMed - indexed for MEDLINE]
Free Article
8.

Time-intensified dexamethasone/cisplatin/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease.

Josting A, Rudolph C, Reiser M, Mapara M, Sieber M, Kirchner HH, Dörken B, Hossfeld DK, Diehl V, Engert A; Participating Centers.

Ann Oncol. 2002 Oct;13(10):1628-35.

PMID:
12377653
[PubMed - indexed for MEDLINE]
Free Article
9.

Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi.

Di Renzo N, Brugiatelli M, Montanini A, Vigliotti ML, Cervetti G, Liberati AM, Luminari S, Spedini P, Giglio G, Federico M.

Leuk Lymphoma. 2006 Mar;47(3):473-9.

PMID:
16396771
[PubMed - indexed for MEDLINE]
10.

High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease.

Bonfante V, Viviani S, Devizzi L, Di Russo A, Di Nicola M, Magni M, Matteucci P, Grisanti S, Valagussa P, Bonadonna G, Gianni AM.

Eur J Haematol Suppl. 2001 Jul;64:51-5.

PMID:
11486403
[PubMed - indexed for MEDLINE]
11.

Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group.

Baetz T, Belch A, Couban S, Imrie K, Yau J, Myers R, Ding K, Paul N, Shepherd L, Iglesias J, Meyer R, Crump M.

Ann Oncol. 2003 Dec;14(12):1762-7.

PMID:
14630682
[PubMed - indexed for MEDLINE]
Free Article
12.

[Efficacy of GDP regimen (gemcitabine, dexamethasone, and cisplatin) on relapsed or refractory aggressive non-Hodgkin's Lymphoma: a report of 24 cases].

Fan Y, Huang ZY, Luo LH, Yu HF.

Ai Zheng. 2008 Nov;27(11):1222-5. Chinese.

PMID:
19000458
[PubMed - indexed for MEDLINE]
13.

The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin's disease.

Fermé C, Bastion Y, Lepage E, Berger F, Brice P, Morel P, Gabarre J, Nédellec G, Reman O, Chéron N, et al.

Ann Oncol. 1995 Jul;6(6):543-9.

PMID:
8573532
[PubMed - indexed for MEDLINE]
14.

Gemcitabine, etoposide, cisplatin, and dexamethasone in patients with refractory or relapsed non-Hodgkin's lymphoma.

Kim KH, Joo YD, Sohn CH, Shin HJ, Chung JS, Cho GJ, Shin SH, Kim YS, Lee WS.

Korean J Intern Med. 2009 Mar;24(1):37-42. doi: 10.3904/kjim.2009.24.1.37.

PMID:
19270480
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Pilot study of an outpatient-based approach for advanced lymphoma using vinorelbine, gemcitabine and filgrastim.

Spencer A, Reed K, Arthur C.

Intern Med J. 2007 Nov;37(11):760-6. Epub 2007 Jun 2.

PMID:
17542998
[PubMed - indexed for MEDLINE]
16.

Combination chemotherapy with gemcitabine and vinorelbine in the treatment of patients with relapsed or refractory small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.

Hainsworth JD, Burris HA 3rd, Erland JB, Baker M, Scullin DC Jr, Shaffer DW, Greco FA; Minnie Pearl Cancer Research Network.

Cancer Invest. 2003 Apr;21(2):193-9.

PMID:
12743984
[PubMed - indexed for MEDLINE]
17.

Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group.

Papageorgiou ES, Tsirigotis P, Dimopoulos M, Pavlidis N, Fountzilas G, Papageorgiou S, Economopoulos T; Hellenic Cooperative Oncology Group.

Eur J Haematol. 2005 Aug;75(2):124-9.

PMID:
16000128
[PubMed - indexed for MEDLINE]
18.

Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer.

Isokangas OP, Knuuttila A, Halme M, Mäntylä M, Lindström I, Nikkanen V, Viren M, Joensuu H, Mattson K.

Ann Oncol. 1999 Sep;10(9):1059-63.

PMID:
10572603
[PubMed - indexed for MEDLINE]
Free Article
19.

Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation.

Fernández de Larrea C, Martínez C, Gaya A, López-Guillermo A, Rovira M, Fernández-Avilés F, Lozano M, Bosch F, Esteve J, Nomdedeu B, Montserrat E, Carreras E.

Ann Oncol. 2010 Jun;21(6):1211-6. doi: 10.1093/annonc/mdp487. Epub 2009 Nov 4.

PMID:
19889622
[PubMed - indexed for MEDLINE]
Free Article
20.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk